IP Library Granted Patent US 8,518,441
Granted Patent B2
US 8,518,441 · App. 11/433,589 · Granted Aug 27, 2013

Solid dispersions or solid dispersion pharmaceutical preparations of phenylalanine derivatives

Inventors: Hiroyuki Higuchi (Kawasaki, JP); Hirokazu Hagio (Kawasaki, JP); Kenichi Ogawa (Kawasaki, JP); Akira Yabuki (Kawasaki, JP)
Assignee: Ajinomoto Co., Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,518,441
App. No.
11/433,589
Granted
Aug 27, 2013
Kind
B2
Abstract

The present invention provides solid dispersions or solid dispersion pharmaceutical preparations containing a water-soluble polymeric substance(s) and a phenylalanine compound of the formula (1) or pharmaceutically acceptable salts thereof, wherein A represents the formula (2) and the like, B represent an alkoxy group and the like, E represents a hydrogen atom and the like, D represents a substituted phenyl group and the like, T, U and V represent a carbonyl group and the like, Arm represents a benzene ring and the like, R1 represents an alkyl group and the like, R2, R3, and R4 may be the same or different from one another and each represent a hydrogen atom, a substituted amino group and the like, and J and J′ represent a hydrogen atom and the like; production methods thereof; and solubilized pharmaceutical preparations containing a solubilizer(s) and the compound (I) or pharmaceutically acceptable salts thereof. According to the solid dispersion pharmaceutical preparations or solubilized pharmaceutical preparations, though they contain the phenylalanine compound of the formula (1) that is a poorly-soluble drug as an active ingredient, the pharmaceutical preparations having high solubility and oral absorbability can be obtained.

Claims (13)

1. A solid dispersion, comprising a phenylalanine compound of formula (A) or a pharmaceutically acceptable salt thereof dispersed in amorphous state in methylcellulose wherein the weight ratio of said compound of formula (A) or pharmaceutically acceptable salt thereof to said methylcellulose is 1:0.1 to 1:100

2. The solid dispersion according to claim 1 , wherein said dispersion further comprises hydroxypropylmethylcellulose.

3. The solid dispersion according to claim 1 , wherein the weight ratio of said compound of formula (A) or pharmaceutically acceptable salt thereof to said methylcellulose is 1:0.25 to 1:20.

4. The solid dispersion according to claim 1 , wherein the weight ratio of said compound of formula (A) or pharmaceutically acceptable salt thereof to said methycellulose is 1:05 to 1:10.

5. A solid dispersion pharmaceutical preparation which is prepared by processing a solid dispersion according to claim 1 .

6. A solid dispersion pharmaceutical preparation, comprising a solid dispersion according to claim 1 and one or more foaming agents.

7. A solid dispersion pharmaceutical preparation which is prepared by coating a core component comprising a solid dispersion according to claim 1 with one or more coating agents.

8. The solid dispersion pharmaceutical preparation according to claim 7 , wherein said one or more coating agents is one or more coating agents selected from the group consisting of aminoalkyl methacrylate copolymer E, hydroxypropylmethylcellulose, methylcellulose, methylhydroxyethylcellulose, opadry, carmellose calcium, carmellose sodium, polyvinylpyrrolidone, polyvinyl alcohol, dextrin, pullulan, gelatin, agar, gum Arabic, and mixtures thereof.

9. A method for producing a solid dispersion according to claim 1 , comprising dissolving or dispersing the compound of formula (A) or a pharmaceutically acceptable salt thereof in one or more organic solvents together with said methylcellulose, and then removing said one or more organic solvents.

10. A method for producing a solid dispersion according to claim 1 , comprising dissolving or dispersing the compound of formula (A) or a pharmaceutically acceptable salt thereof in said methylcellulose under heating, to obtain a mixture, and then cooling said mixture.

11. A method for producing a solid dispersion according to claim 1 , comprising dissolving or dispersing the compound of formula (A) or a pharmaceutically acceptable salt thereof in said methylcellulose under heating and under pressure, to obtain a mixture, and then cooling said mixture.

12. A method for producing a solid dispersion according to claim 1 , comprising mixing the compound of formula (A) or a pharmaceutically acceptable salt thereof together with said methylcellulose, and to obtain a mixture, then grinding the mixture.

13. The method of claim 9 , wherein said one or more organic solvents is one or more organic solvents selected from the group consisting of a halogenated hydrocarbon, an alcohol, and mixtures thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2016
From: AJINOMOTO CO., INC.
To: EA PHARMA CO., LTD.
Reel/Frame 039094/0087 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 15, 2006
From: HIGUCHI, HIROYUKI; HAGIO, HIROKAZU; OGAWA, KENICHI; YABUKI, AKIRA
To: AJINOMOTO CO., INC.
Reel/Frame 017896/0162 →
Priority Claims (1)
JP 2003-385501 · Nov 14, 2003 · national
Continuity (2)
Continuation PCTJP2004016942 · Nov 15, 2004
Related Publication 20060204572A1 · Sep 14, 2006